Invention Grant
- Patent Title: Orally disintegrable tablet
-
Application No.: US14891930Application Date: 2014-05-20
-
Publication No.: US10004691B2Publication Date: 2018-06-26
- Inventor: Tetsuya Kawano , Yumiko Ishii
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceuticals Company Limited
- Current Assignee: Takeda Pharmaceuticals Company Limited
- Current Assignee Address: JP Osaka
- Agency: Hamre, Schumann, Mueller & Larson, P.C.
- Priority: JP2013-107072 20130521
- International Application: PCT/JP2014/063307 WO 20140520
- International Announcement: WO2014/189034 WO 20141127
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A61K9/00 ; A61K31/4439 ; A61K31/616 ; A61K9/50

Abstract:
Provided is an orally disintegrating tablet which shows high stability of the active ingredients (acetylsalicylic acid and PPI), and expresses the pharmacological effects of the active ingredients stably and rapidly after administration. A multiple-unit type orally disintegrating tablet containing enteric-coated micro granules containing acetylsalicylic acid, enteric-coated micro granules containing a proton pump inhibitor, and an additive, wherein an enteric coating layer of the enteric-coated micro granules containing acetylsalicylic acid contains an aqueous enteric polymer base and a sustained-release base.
Public/Granted literature
- US20160089338A1 ORALLY DISINTEGRABLE TABLET Public/Granted day:2016-03-31
Information query